Updates

Kalibrate

October 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Kalibrate is presenting its full year results in US dollars for the first time. FY14 sales for the full year were up 19% to US$28.8m. Pretax profit was up from US$2.4m to US$2.9m, for eps of 8.9 cents. Net cash was US$9.6mBoth parts of the business delivered growth: Planning (software to quantify how a change in price will impact on consumer demand) +19%; Pricing (software for site evaluation and network planning) +20% and all geographical regions also grew year-on-year.The year saw the first combined Pricing/Planning sale into a brand new customer in Europe; first sales in Malaysia, New Zealand and Brazil, and a major managed services win to a global oil retailer in December, which has outsourced the management of their enti ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Vislink

Growth Portfolio - October '14

Kalibrate (July 2017)

Kalibrate (October 2015)

Kalibrate (April 2015)

Kalibrate - Shares on cusp of breakout (September 2014)

Kalibrate - Comfortably ahead of market forecasts (July 2014)

Kalibrate (April 2014)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X